ストックスクリーナーアプリを入手
89.90
0.13%
0.12
前日終値:
$89.78
開ける：
$90.21
24時間の取引高:
2.62M
Relative Volume:
0.62
時価総額：
$51.82B
収益：
$6.30B
当期純損益:
$1.07B
株価収益率:
48.84
EPS:
1.8406
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
-0.34%
1か月 パフォーマンス:
+0.33%
6か月 パフォーマンス:
+5.49%
1年 パフォーマンス:
+11.04%
1日の値動き範囲:
$88.40
$90.21
1週間の範囲:
$88.40
$92.95
52週間の値動き範囲:
$72.30
$96.29
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, MDT, SYK, BSX
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-01 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2026-01-09 | アップグレード | TD Cowen | Hold → Buy |
| 2025-12-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | アップグレード | Jefferies | Hold → Buy |
| 2025-10-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | アップグレード | Stifel | Hold → Buy |
| 2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | Truist | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
| 2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | ダウングレード | Stifel | Buy → Hold |
| 2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 開始されました | Mizuho | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-27 | 繰り返されました | Citigroup | Buy |
| 2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Buy |
| 2022-01-27 | 繰り返されました | UBS | Neutral |
| 2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
| 2021-07-30 | 繰り返されました | Jefferies | Buy |
| 2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
| 2021-07-30 | 繰り返されました | Stifel | Buy |
| 2021-07-30 | 繰り返されました | UBS | Neutral |
| 2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Underperform |
| 2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Outperform |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-09-23 | 開始されました | Piper Jaffray | Overweight |
| 2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Azimuth Capital Investment Management LLC Decreases Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
B. Metzler seel. Sohn & Co. AG Lowers Position in Edwards Lifesciences Corporation $EW - MarketBeat
Nykredit A S Makes New $20.64 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit 2026 - BioSpace
Empowered Funds LLC Buys New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW) SVP, Corporate Controller Andrew Dahl Sells 544 Shares - GuruFocus
NS Partners Ltd Reduces Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Van ECK Associates Corp Decreases Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) SVP Sells 544 Shares of Stock - MarketBeat
Edwards Lifesciences SVP sells $49,533 in stock - Investing.com
Breadth Narrows, Software Shines; Fortinet, Edwards Lifesciences, UBS In FocusVideoIBD - Investor's Business Daily
Edwards Lifesciences (NYSE: EW) exec plans $49K stock sale - stocktitan.net
Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock - Barchart.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
24,532 Shares in Edwards Lifesciences Corporation $EW Purchased by Kingsview Wealth Management LLC - MarketBeat
19,972 Shares in Edwards Lifesciences Corporation $EW Purchased by United Capital Financial Advisors LLC - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Alyeska Investment Group L.P. - MarketBeat
Wellington Management Group LLP Lowers Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Jefferies Financial Group Inc. Invests $3.58 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW) Insider Sells 2,644 Shares; Valuation Remains Fairly Valued - GuruFocus
Edwards Lifesciences (NYSE:EW) VP Sells 2,644 Shares - MarketBeat
Edwards Lifesciences' Donald E. Bobo, Jr. to Retire as Corporate VP; Successor Search Underway - TradingView
MASTERINVEST Kapitalanlage GmbH Purchases New Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Insider Move: Daveen Chopra Exercises Options, Realizing $551K At Edwards Lifesciences - benzinga.com
Edwards Lifesciences (NYSE: EW) exec may sell 1,240 shares - stocktitan.net
Hsbc Holdings PLC Sells 144,364 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Legal & General Group Plc Buys New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Commerce Bank Buys Shares of 34,501 Edwards Lifesciences Corporation $EW - MarketBeat
Daiichi Life Insurance Co. Ltd. Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Great Lakes Advisors LLC Invests $1.25 Million in Edwards Lifesciences Corporation $EW - MarketBeat
WealthShield Partners LLC Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by NewEdge Advisors LLC - MarketBeat
40,124 Shares in Edwards Lifesciences Corporation $EW Acquired by Wealthfront Advisers LLC - MarketBeat
Tocqueville Asset Management L.P. Makes New $5.37 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Fairtree Asset Management Pty Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Bank of New York Mellon Corp Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event? - Yahoo Finance
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Edwards Lifesciences stock holds gains as Q2 growth supports 2026 outlook - Ad-hoc-news.de
Should You Hold Edwards Lifesciences Stock in Your Portfolio? - Yahoo Finance
Global Cardiovascular Devices Market to Reach $101.6 Billion by 2030, Says BCC Research Analyst - GlobeNewswire
524,490 Shares in Edwards Lifesciences Corporation $EW Acquired by Danske Bank A S - MarketBeat
Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings - Yahoo Finance
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years - Benzinga
Aristotle Capital Management, LLC's Edwards Lifesciences Corp(EW) Holding History - GuruFocus
Mitsubishi UFJ Asset Management Co. Ltd. Takes $126.12 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care - Yahoo Finance
BlackRock Inc. Acquires New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences stock holds steady as analysts see upside - AD HOC NEWS
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
1.81%
2.02%
大文字化:
|
ボリューム (24 時間):